532 related articles for article (PubMed ID: 27384562)
1. Less Is More: Substrate Reduction Therapy for Lysosomal Storage Disorders.
Coutinho MF; Santos JI; Alves S
Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27384562
[TBL] [Abstract][Full Text] [Related]
2. Substrate reduction therapy.
Platt FM; Jeyakumar M
Acta Paediatr; 2008 Apr; 97(457):88-93. PubMed ID: 18339196
[TBL] [Abstract][Full Text] [Related]
3. [Current therapeutic strategies in lysosomal disorders].
Kaminsky P; Lidove O
Presse Med; 2014 Nov; 43(11):1174-84. PubMed ID: 24863660
[TBL] [Abstract][Full Text] [Related]
4. Substrate deprivation therapy: a new hope for patients suffering from neuronopathic forms of inherited lysosomal storage diseases.
Jakóbkiewicz-Banecka J; Wegrzyn A; Wegrzyn G
J Appl Genet; 2007; 48(4):383-8. PubMed ID: 17998597
[TBL] [Abstract][Full Text] [Related]
5. Substrate reduction therapy of glycosphingolipid storage disorders.
Aerts JM; Hollak CE; Boot RG; Groener JE; Maas M
J Inherit Metab Dis; 2006; 29(2-3):449-56. PubMed ID: 16763917
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary involvement in selected lysosomal storage diseases and the impact of enzyme replacement therapy: A state-of-the art review.
Jezela-Stanek A; Chorostowska-Wynimko J; Tylki-Szymańska A
Clin Respir J; 2020 May; 14(5):422-429. PubMed ID: 31912638
[TBL] [Abstract][Full Text] [Related]
7. Miglustat: substrate reduction therapy for glycosphingolipid lysosomal storage disorders.
Lachmann RH
Drugs Today (Barc); 2006 Jan; 42(1):29-38. PubMed ID: 16511609
[TBL] [Abstract][Full Text] [Related]
8. A Comparative Study on the Alterations of Endocytic Pathways in Multiple Lysosomal Storage Disorders.
Rappaport J; Manthe RL; Solomon M; Garnacho C; Muro S
Mol Pharm; 2016 Feb; 13(2):357-368. PubMed ID: 26702793
[TBL] [Abstract][Full Text] [Related]
9. Substrate reduction therapy for lysosomal storage diseases.
Cox TM
Acta Paediatr Suppl; 2005 Mar; 94(447):69-75; discussion 57. PubMed ID: 15895716
[TBL] [Abstract][Full Text] [Related]
10. Genetic Substrate Reduction Therapy: A Promising Approach for Lysosomal Storage Disorders.
Coutinho MF; Santos JI; Matos L; Alves S
Diseases; 2016 Nov; 4(4):. PubMed ID: 28933412
[TBL] [Abstract][Full Text] [Related]
11. Gene therapy for lysosomal storage diseases: the lessons and promise of animal models.
Ellinwood NM; Vite CH; Haskins ME
J Gene Med; 2004 May; 6(5):481-506. PubMed ID: 15133760
[TBL] [Abstract][Full Text] [Related]
12. Newborn screening for lysosomal storage disorders.
Nakamura K; Hattori K; Endo F
Am J Med Genet C Semin Med Genet; 2011 Feb; 157C(1):63-71. PubMed ID: 21312327
[TBL] [Abstract][Full Text] [Related]
13. Changes of bone metabolism in seven patients with Gaucher disease treated consecutively with imiglucerase and miglustat.
Mikosch P; Reed M; Baker R; Holloway B; Berger L; Mehta AB; Hughes DA
Calcif Tissue Int; 2008 Jul; 83(1):43-54. PubMed ID: 18553043
[TBL] [Abstract][Full Text] [Related]
14. Reduced cerebellar neurodegeneration after combined therapy with cyclodextrin/allopregnanolone and miglustat in NPC1: a mouse model of Niemann-Pick type C1 disease.
Maass F; Petersen J; Hovakimyan M; Schmitt O; Witt M; Hawlitschka A; Lukas J; Rolfs A; Wree A
J Neurosci Res; 2015 Mar; 93(3):433-42. PubMed ID: 25400034
[TBL] [Abstract][Full Text] [Related]
15. Treatable lysosomal storage diseases in the advent of disease-specific therapy.
Peters H; Ellaway C; Nicholls K; Reardon K; Szer J
Intern Med J; 2020 Nov; 50 Suppl 4():5-27. PubMed ID: 33210402
[TBL] [Abstract][Full Text] [Related]
16. [Treatment prospects of lysosomal storage disorders].
Reismann P; Tulassay Z
Orv Hetil; 2008 Jun; 149(25):1171-9. PubMed ID: 18547894
[TBL] [Abstract][Full Text] [Related]
17. Neurological manifestations in lysosomal storage disorders - from pathology to first therapeutic possibilities.
Hoffmann B; Mayatepek E
Neuropediatrics; 2005 Oct; 36(5):285-9. PubMed ID: 16217702
[TBL] [Abstract][Full Text] [Related]
18. New prospects for the treatment of lysosomal storage diseases.
Schiffmann R; Brady RO
Drugs; 2002; 62(5):733-42. PubMed ID: 11929328
[TBL] [Abstract][Full Text] [Related]
19. Enzyme replacement therapy for lysosomal diseases: lessons from 20 years of experience and remaining challenges.
Desnick RJ; Schuchman EH
Annu Rev Genomics Hum Genet; 2012; 13():307-35. PubMed ID: 22970722
[TBL] [Abstract][Full Text] [Related]
20. Gene therapy for the lysosomal storage disorders.
Cabrera-Salazar MA; Novelli E; Barranger JA
Curr Opin Mol Ther; 2002 Aug; 4(4):349-58. PubMed ID: 12222873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
